Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study in Combination of Resminostat and Sorafenib in Patients With Advanced Hepatocellular Carcinoma Previously Untreated With Systemic Chemotherapy

NCT02400788 is registered in ClinicalTrials.gov with Yakult Honsha Co., LTD as lead sponsor.

NCT NCT02400788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02400788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study in Combination of Resminostat and Sorafenib in Patients With Advanced Hepatocellular Carcinoma Previously Untreated With Systemic Chemotherapy
Lead sponsor
Yakult Honsha Co., LTD
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2013
Completion date
October 31, 2016
Enrollment
179 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma